Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michele Pereira Moreira"'
Simvastatin-loaded nanoemulsions: development, characterization, stability study and toxicity assays
Autor:
Bruna Costabeber Guerino, Marina Lopes Machado, Michele Pereira Moreira, Julien Wergutz, Renata Gancine Budel, Luciana Maria Fontanari Krause, Félix Alexandre Antunes Soares, Carina Rodrigues Boeck, Aline Ferreira Ourique
Publikováno v:
Therapeutic Delivery. 11:497-505
Aim: The aim of this study is to prepare and characterize simvastatin-loaded nanoemulsions (SIM-LN) as well as evaluate their physicochemical properties and toxicity. Methodology & results: The SIM-LN were prepared, their characteristics evaluated fo
Autor:
Patrícia Gomes, Leonardo Quintana Soares Lopes, Michele Pereira Moreira, Carina Rodrigues Boeck, Rosane Souza da Silva, Aline Franzen da Silva, Luiza Reali Nazario, Denise Ajala da Silva, Renata Gancine Budel, Ana Júlia Figueiró Dalcin, Félix Alexandre Antunes Soares, Roberto Christ Vianna Santos, Julia Huppes Majolo
Publikováno v:
Colloids and Surfaces B: Biointerfaces, 188. ELSEVIER SCIENCE BV
Naringin is a flavonoid widely known for its pharmacological properties, such as: anti-inflammatory and antioxidant ones, being an ally to avoid oxidative damage. Although naringin is an active easily found in citrus fruits, it has low bioavailabilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c37732ec0792bd7b725e4144cc4403a
https://research.rug.nl/en/publications/26168c5a-381b-4b78-8679-c0c0376db21a
https://research.rug.nl/en/publications/26168c5a-381b-4b78-8679-c0c0376db21a
Autor:
Mauro Schneider Oliveira, Michele Rechia Fighera, Mayara Lutchemeyer de Freitas, Luiz Fernando Freire Royes, Ana Flávia Furian, Fernanda Kulinski Mello, Viviane Nogueira de Zorzi, Karine Gabriela da Costa, Michele Pereira Moreira, Bruna Neuberger, Naieli Schiefelbein Souto
Publikováno v:
Epilepsy research. 160
Thromboxane A2 (TXA2) is an important eicosanoid in the cardiovascular system, and increasing evidence suggests that TXA2 receptors (TPs) and their ligands may constitute valuable tools for the development of neuroprotective drugs. However, the role